Shin-Etsu Chemical C (SHECY) 17.2300 $SHECY FMC Corp.

New Post Public Reply Private Reply Replies (0) Message Board

Sep 21, 2016 at 5:13 AM

Shin-Etsu Chemical C (SHECY) 17.2300 $SHECY

FMC Corp. (FMC) Announces Hike in Butyllithium Price
Zacks Equity Research - Zacks Investment Research - Wed Sep 14, 7:53AM CDT
FMC Corp. (FMC) said that it will increase the prices for its specialty organics products across all global regions.
IOSP: 59.13 (+0.06), FMC: 47.34 (-0.44), IPHS: 37.36 (-0.28)

Air Products Rolls Out First Port Manatee LNG Heat Exchanger
Zacks Equity Research - Zacks Investment Research - Wed Sep 14, 7:11AM CDT
Air Products and Chemicals Inc.'s (APD) has rolled out its first completed liquefied natural gas (LNG) heat exchanger, produced at its new Manatee County, FL facility.
IOSP: 59.13 (+0.06), APD: 147.07 (+0.27)

PPG Industries Introduces Advanced Sound Absorbing Roving
Zacks Equity Research - Zacks Investment Research - Wed Sep 14, 7:09AM CDT
PPG Industries (PPG) has introduced a new composition of direct-draw fiber glass roving, Innofiber TS 2402, to absorb sound.
IOSP: 59.13 (+0.06), PPG: 101.26 (+0.18)

PPG Industries to Exhibit Packaging Coatings in New York City
Zacks Equity Research - Zacks Investment Research - Mon Sep 12, 7:20AM CDT
PPG Industries' (PPG) packaging coatings business will be displaying at the Aerosol and Dispensing Forum in New York City from Sep 13-14.
IOSP: 59.13 (+0.06), PPG: 101.26 (+0.18)

Air Products' (APD) Separation of Versum Approved by Board
Zacks Equity Research - Zacks Investment Research - Mon Sep 12, 7:05AM CDT
Air Products and Chemicals Inc.'s (APD) board of directors has approved the separation of the company's Electronic Materials Division business to form Versum Materials Inc.
IOSP: 59.13 (+0.06), APD: 147.07 (+0.27)

PPG Industries to Display Advanced Coatings at Vehicle Expo
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 6:24AM CDT
PPG Industries (PPG) will be displaying its entire range of advanced transparent coatings at the SID Vehicle Displays Detroit symposium and expo.
IOSP: 59.13 (+0.06), PPG: 101.26 (+0.18)

Air Products Inaugurates Specialty Gas Plant in South Korea
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 6:35AM CDT
Air Products and Chemicals Inc. (APD) has opened a new advanced non-electronics specialty gas and helium transfill center in Ochang, North Chungcheong, South Korea.
IOSP: 59.13 (+0.06), APD: 147.07 (+0.27), IPHS: 37.36 (-0.28)

Air Products' (APD) Spin-Off Versum to Present in Taiwan
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 7:08AM CDT
Air Products and Chemicals Inc.'s (APD) Electronics Materials business spin-off, Versum, will showcase its capabilities publicly at Semicon in Taiwan from Sep 7-9.
IOSP: 59.13 (+0.06), APD: 147.07 (+0.27), IPHS: 37.36 (-0.28)

PPG Industries (PPG) Opens New Distribution Center in Mexico
Zacks Equity Research - Zacks Investment Research - Thu Aug 11, 4:49AM CDT
PPG Industries (PPG) has opened a new distribution center in Hermosillo, Sonora, Mexico.
IOSP: 59.13 (+0.06), PPG: 101.26 (+0.18), SCL: 70.07 (-0.45)

PPG Industries (PPG) to Upgrade Chester Fiber Glass Facility
Zacks Equity Research - Zacks Investment Research - Wed Aug 10, 7:29AM CDT
PPG Industries (PPG) has announced its decision to upgrade its fiber glass manufacturing facility in Chester, SC by investing $20 million.
IOSP: 59.13 (+0.06), PPG: 101.26 (+0.18), SCL: 70.07 (-0.45)

FMC Corp (FMC) Beats on Q2 Earnings, Ups FY16 EPS View
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 7:03AM CDT
FMC Corp. (FMC) reported a profit of $65.2 million or 49 cents per share in second-quarter 2016.
AXLL: 33.00 (+0.02), FMC: 47.34 (-0.44), SCL: 70.07 (-0.45)

LyondellBasell (LYB) Q2 Earnings & Sales Miss Estimates
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:27AM CDT
LyondellBasell Industries (LYB) reported adjusted earnings from continuing operations of $2.45 per share for second-quarter 2016.
LYB: 77.54 (-0.90), AXLL: 33.00 (+0.02), SCL: 70.07 (-0.45)

Methanex (MEOH) Q2 Loss Lower than Expected, Sales Beat
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 8:09AM CDT
Methanex Corporation's (MEOH) recorded net loss (attributable to Methanex shareholders) of $3 million or 8 cents per share in the second quarter of 2016.
AXLL: 33.00 (+0.02), SCL: 70.07 (-0.45), MEOH: 28.90 (-0.63)

Eastman Chemical (EMN) Misses Q2 Earnings & Sales Estimates
Zacks Equity Research - Zacks Investment Research - Fri Jul 29, 7:59AM CDT
Eastman Chemical's (EMN) second-quarter revenues and adjusted earnings trailed the respective Zacks Consensus Estimate.
EMN: 64.30 (-0.50), AXLL: 33.00 (+0.02), SCL: 70.07 (-0.45)

Air Products (APD) Q3 Earnings Beat Estimates, View Raised
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 9:42AM CDT
Air Products and Chemicals, Inc. (APD) surpassed earnings expectations in third-quarter fiscal 2016 with adjusted earnings of $1.92 per share.
AXLL: 33.00 (+0.02), SCL: 70.07 (-0.45), APD: 147.07 (+0.27)

Praxair (PX) Beats on Q2 Earnings & Revenues; Revises View
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 8:00AM CDT
Praxair Inc.'s (PX) for second-quarter 2016 adjusted earnings of $1.39 per share came above the Zacks Consensus Estimate of $1.35, while revenues of $2.665 billion exceeded our estimate of $2.61 billion.
AXLL: 33.00 (+0.02), PX: 117.61 (-0.20), SCL: 70.07 (-0.45)

The Road Ahead - Featured Research on Danone, Industria de Diseno Textil, Shin-Etsu Chemical, and Sonic Healthcare
ACCESSWIRE - Fri Jan 22, 7:35AM CST
NEW YORK, NY / ACCESSWIRE / January 22, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Danone SA (OTC: DANOY), Industria de Diseno Textil SA (OTC: IDEXY), Shin-Etsu Chemical Co. Ltd. (OTC: SHECY) and Sonic Healthcare Ltd. (OTC: SKHCY). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...